Algen Biotechnologies

Using CRISPR to find treatments for cancer and inflammation

Algen Biotechnologies is a business in healthcare based in San Francisco, CA, USA.

Profile

Algen is using CRISPR to uncover disease-driving RNA messages to find treatments for cancer, inflammation and diseases with high unmet needs. We are harnessing the power of CRISPR and machine learning to find first-in-class drugs that modulate RNA messages at single-cell resolution. Algen's founders are bioengineer from Jennifer Doudna Lab and biotech commercialization expert, teamed up with experienced pharmaceutical executives.

The company sits in the healthcare segment, where it competes on its core product or service.

The company is recorded as being based in San Francisco, CA, USA.

It is recorded at the Winter 2020 stage.

Its team size is recorded as 15 employees.

Website: www.algenbio.com